Artificial Intelligence in the Cancer Market

  • Published on 2025-11-10
  • Report Code: 842
  • 170-350 pages
Artificial Intelligence in the Cancer Market

Artificial Intelligence in the Cancer Market : Segmented by Product Type (Surgery, Radiotherapy, Chemotherapy, Immunotherapy, Phototherapy, Targeted therapy, Gene Therapy, Sonodynamic Therapy); Cancer Type (Breast cancer, Lung cancer, Melanoma cancer, Colorectal cancer, Prostate cancer, Others); By End User (Diagnosis, Therapy, Prognosis, Health Management, Research) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Artificial Intelligence in Cancer Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Artificial Intelligence in Cancer Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Artificial Intelligence in Cancer Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Artificial Intelligence in Cancer Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Latin America: (Brazil, Mexico, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Middle East and Africa, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Surgery: Market Share (2020-2030F)
      1. Radiotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Phototherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Gene Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Sonodynamic Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Cancer type: Market Share (2020-2030F)
      1. Breast cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Lung cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Melanoma cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Colorectal cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Prostate cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By End-User: Market Share (2020-2030F)
      1. Diagnosis, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Prognosis, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Health Management, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Research, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Microsoft Corporation
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. NVIDIA
  3. IBM
  4. Intel
  5. Siemens Healthineers
  6. GE Healthcare
  7. Digital Diagnostics
  8. Xilinx
  9. InformAI
  10. Enlitic
  11. Day Zero Diagnostics
  12. Aidence 
  13. Butterfly Network, Inc.
  14. Prognos
  15. Zebra Medical Vision

Consultant Recommendation

**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients